autologous Epstein-Barr virus-specific cytotoxic T lymphocytes
Sponsors
Northwestern University, National Cancer Centre, Singapore
Conditions
Head and Neck CancerLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Phase 2
Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation
CompletedNCT00005606
Start: 2000-02-29End: 2003-09-30Updated: 2012-06-06
Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer
NCT00690872
Start: 2008-07-31Target: 35Updated: 2009-06-29